Kristin Peterson
Biographic Data
| ID | 122127 |
|---|---|
| NAME | Kristin Peterson |
| GIVEN NAMES | Kristin |
| FAMILY NAME | Peterson |
| SIGNATURE | PETERSON K |
| AFFILIATIONS | University of California, Irvine |
| ORCID | 0000-0001-7708-1345 |
| VERIFIED | Yes |
| TOTAL WORKS | 13 |
| TOTAL CITATIONS | 14 |
| AUTHOR COUNT | 13 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2001 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 2 |
Q by Jude Chehab (review)
Hispanic/Latina women's perceived barriers and suggestions for self-monitoring food and exercise: A qualitative study
Self-monitoring (SM) of diet and exercise is a useful strategy for weight management, either as a standalone treatment or as part of behavioral weight loss (BWL) interventions. However, rates of adherence to SM are often low among Hispanic/Latina women. In this qualitative study, 14 Hispanic/Latina women with overweight or obesity attended focus groups and were asked to identify perceived barriers to SM and suggestions for improving adherence. Tr…
The Racialization of Drug Fakery and Pharmaceutical Markets
In this article, I show that fake drugs circulate widely in markets that chronically experience non-equilibrium. Moreover, those who manufacture, buy, and sell low priced drugs for African markets are negotiating chronic market volatility and downward pricing pressures that are transnational in scope. I argue that global policy experts; state, regional, and global regulation agencies and organizations; and international NGOs that have stakes in e…
Anthropology and Liberation: A Review of Cedric Robinson’s An Anthropology of Marxism
Fungible Life: Experiment in the Asian City of Life
Phantom Epistemologies
A research alliance
This article explores a research alliance across fields and continents in the wake of the early and controversial HIV-prevention clinical trials of pre-exposure prophylaxis (PrEP). Our research set out to understand why three trial arms prematurely closed while another was refused approval from the relevant institutional review board. We conducted ethnographic research on 'what happened' at two of the sites. Over time our research strategy cohere…
Acknowledging the 2015 Anthony Leeds Prize in Urban Anthropology
Debating Ethics in HIV Research: Gaps between Policy and Practice in N igeria
HIV prevention is a critical health issue in N igeria; a country that has one of the worst HIV epidemic profiles in the world. With 270,000 new infections in 2012, N igeria is a prime site for HIV prevention research. One effect of the HIV epidemic has been to revolutionalise ethical norms for the conduct of research: it is now considered unethical to design and implement HIV related studies without community engagement. Unfortunately, there is v…
Saying 'No' to PrEP research in Malawi: What constitutes 'failure' in offshored HIV prevention research
Between 2004 and 2005, the first multi-sited clinical trial tested whether an existing, marketed antiretroviral drug, Tenofovir (TDF), could prevent HIV transmission. Referred to as pre-exposure prophylaxis (PrEP), most of these trial sites prematurely closed down. Two sites located in Cambodia and Cameroon received international media attention. But little attention was drawn to sites in Malawi and Nigeria, where university ethicists and researc…
On the monopoly: Speculation, pharmaceutical markets, and intellectual property law in Nigeria
The drug patent monopoly has been described as a key deterrent to Africans’ access to brand‐name, life‐saving drugs. Research in Nigeria, however, shows that another factor restricts access in that country: Brand‐name pharmaceutical companies’ pricing and marketing strategies keep patented drugs off the market. In this article, I retheorize the question of monopoly in the pharmaceuticals industry. I first track the historical precedents of this p…
Speculative Markets: Drug Circuits and Derivative Life in Nigeria
Benefit Sharing for All: Bioprospecting NGOs, Intellectual Property Rights, New Governmentalities
Benefit Sharing for All: Bioprospecting NGOs, Intellectual Property Rights, New Governmentalities
The Racialization of Drug Fakery and Pharmaceutical Markets
In this article, I show that fake drugs circulate widely in markets that chronically experience non-equilibrium. Moreover, those who manufacture, buy, and sell low priced drugs for African markets are negotiating chronic market volatility and downward pricing pressures that are transnational in scope. I argue that global policy experts; state, regional, and global regulation agencies and organizations; and international NGOs that have stakes in e…
Saying 'No' to PrEP research in Malawi: What constitutes 'failure' in offshored HIV prevention research
Between 2004 and 2005, the first multi-sited clinical trial tested whether an existing, marketed antiretroviral drug, Tenofovir (TDF), could prevent HIV transmission. Referred to as pre-exposure prophylaxis (PrEP), most of these trial sites prematurely closed down. Two sites located in Cambodia and Cameroon received international media attention. But little attention was drawn to sites in Malawi and Nigeria, where university ethicists and researc…
A research alliance
This article explores a research alliance across fields and continents in the wake of the early and controversial HIV-prevention clinical trials of pre-exposure prophylaxis (PrEP). Our research set out to understand why three trial arms prematurely closed while another was refused approval from the relevant institutional review board. We conducted ethnographic research on 'what happened' at two of the sites. Over time our research strategy cohere…
Benefit Sharing for All: Bioprospecting NGOs, Intellectual Property Rights, New Governmentalities
On the monopoly: Speculation, pharmaceutical markets, and intellectual property law in Nigeria
The drug patent monopoly has been described as a key deterrent to Africans’ access to brand‐name, life‐saving drugs. Research in Nigeria, however, shows that another factor restricts access in that country: Brand‐name pharmaceutical companies’ pricing and marketing strategies keep patented drugs off the market. In this article, I retheorize the question of monopoly in the pharmaceuticals industry. I first track the historical precedents of this p…
Speculative Markets: Drug Circuits and Derivative Life in Nigeria
Debating Ethics in HIV Research: Gaps between Policy and Practice in N igeria
HIV prevention is a critical health issue in N igeria; a country that has one of the worst HIV epidemic profiles in the world. With 270,000 new infections in 2012, N igeria is a prime site for HIV prevention research. One effect of the HIV epidemic has been to revolutionalise ethical norms for the conduct of research: it is now considered unethical to design and implement HIV related studies without community engagement. Unfortunately, there is v…
Saying 'No' to PrEP research in Malawi: What constitutes 'failure' in offshored HIV prevention research
Between 2004 and 2005, the first multi-sited clinical trial tested whether an existing, marketed antiretroviral drug, Tenofovir (TDF), could prevent HIV transmission. Referred to as pre-exposure prophylaxis (PrEP), most of these trial sites prematurely closed down. Two sites located in Cambodia and Cameroon received international media attention. But little attention was drawn to sites in Malawi and Nigeria, where university ethicists and researc…
Acknowledging the 2015 Anthony Leeds Prize in Urban Anthropology
Phantom Epistemologies
A research alliance
This article explores a research alliance across fields and continents in the wake of the early and controversial HIV-prevention clinical trials of pre-exposure prophylaxis (PrEP). Our research set out to understand why three trial arms prematurely closed while another was refused approval from the relevant institutional review board. We conducted ethnographic research on 'what happened' at two of the sites. Over time our research strategy cohere…
Fungible Life: Experiment in the Asian City of Life
Anthropology and Liberation: A Review of Cedric Robinson’s An Anthropology of Marxism
The Racialization of Drug Fakery and Pharmaceutical Markets
In this article, I show that fake drugs circulate widely in markets that chronically experience non-equilibrium. Moreover, those who manufacture, buy, and sell low priced drugs for African markets are negotiating chronic market volatility and downward pricing pressures that are transnational in scope. I argue that global policy experts; state, regional, and global regulation agencies and organizations; and international NGOs that have stakes in e…
Q by Jude Chehab (review)
Hispanic/Latina women's perceived barriers and suggestions for self-monitoring food and exercise: A qualitative study
Self-monitoring (SM) of diet and exercise is a useful strategy for weight management, either as a standalone treatment or as part of behavioral weight loss (BWL) interventions. However, rates of adherence to SM are often low among Hispanic/Latina women. In this qualitative study, 14 Hispanic/Latina women with overweight or obesity attended focus groups and were asked to identify perceived barriers to SM and suggestions for improving adherence. Tr…
Medicine (5 works) · Political science (5 works) · HIV, Drug Use, Sexual Risk (3 works) · HIV/AIDS Research and Interventions (3 works) · Law (3 works) · Sociology (3 works) · African history and culture studies (2 works) · Business (2 works) · Economics (2 works) · Family medicine (2 works)